This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BURKITT_EXALLC for full statistics.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
27 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
27 |
4. Check minimum number of eventsNone |
27 |
5. Include endpoints |
27 |
6. Filter based on genotype QC (FinnGen only) |
27 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_BURKITT
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphoma non-Hodgkin diffusum
Similar endpoints
↥List of similar endpoints to
Burkitt lymphoma
based on the number of shared cases.
Similar with more cases:
- Burkitt lymphoma, excluding all cancers (controls excluding all cancers)
- Burkitt lymphoma, helper endpoint
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 27 | 8 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 42.46 | 32.14 | 46.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
62
4.88
3.94
12.8
3.1
307.25
13439.68
umol/l
0.79
16
56
7
9
9.99
3.81
1.6
1.6
—
—
—
0
0
7
10
8.96
3.61
4.0
2.6
4.13
3.76
mmol/l
—
7
10
7
11
8.13
3.43
4.3
2.5
222.43
496.36
mg/l
—
7
11
13
48
4.29
3.29
8.2
2.9
—
—
—
0
0
6
8
9.21
3.23
1.2
1.4
—
—
—
0
0
8
17
6.20
3.21
3.0
2.2
—
—
—
0
0
10
31
4.54
3.14
2.6
1.7
—
—
—
0
0
5
5
11.82
3.10
2.2
1.0
—
—
—
0
0
5
5
11.82
3.10
5.0
20.4
11.98
13.96
mg/l
—
5
5
21
119
4.42
3.01
4.6
3.2
0.00
0.00
estimate
—
5
23
5
6
9.84
2.87
2.8
1.3
—
—
—
0
0
8
23
4.49
2.51
2.6
1.5
—
—
—
0
0
5
8
7.35
2.48
3.0
1.4
—
—
—
0
0
5
8
7.35
2.48
3.0
1.4
—
—
—
0
0
20
118
3.66
2.41
6.7
4.8
0.00
0.00
estimate
—
5
23
16
81
3.39
2.39
1.8
2.5
55.81
72.18
nmol/l
1.98
16
75
8
25
4.10
2.32
2.9
1.4
—
—
—
0
0
5
9
6.51
2.32
1.2
1.2
—
—
—
0
0
16
83
3.28
2.27
5.8
2.4
—
—
—
0
0
5
10
5.85
2.17
5.8
2.1
4.82
1.56
ug/l
—
5
10
18
105
3.13
2.15
8.3
5.3
—
—
—
0
0
10
40
3.38
2.12
4.8
2.3
0.00
1.64
e6/l
—
5
23
5
11
5.30
2.03
2.2
4.5
90.00
93.00
%
—
5
11
10
42
3.19
1.95
1.9
3.1
3.89
2.82
mg/l
—
10
37
10
42
3.19
1.95
4.8
2.2
0.20
0.64
e6/l
—
5
25
5
14
4.12
1.69
34.4
10.7
0.99
1.30
mg/l
—
5
14
7
29
2.89
1.51
18.6
13.6
23.90
26.23
mmol/l
—
7
29
15
90
2.50
1.44
4.3
3.4
—
—
—
0
0
22
166
2.75
1.24
6.5
3.8
13.82
10.78
mm/h
0.50
22
154
7
37
2.20
1.03
18.1
9.7
5.56
1.40
mmol/l
—
7
27
13
83
2.09
0.99
5.2
2.7
450.54
163.54
ug/l
0.74
13
77
5
23
2.43
0.81
24.6
11.5
26.80
24.30
mmol/l
—
5
23
5
25
2.22
0.77
28.8
6.1
—
—
—
0
0
19
219
0.55
0.69
4.1
3.6
1.22
1.34
mmol/l
1.00
19
200
17
132
1.78
0.63
11.8
10.8
6.45
6.72
mmol/l
0.22
17
119
20
222
0.62
0.52
4.3
4.0
2.74
2.69
mmol/l
0.08
20
205
20
221
0.63
0.51
4.0
3.7
4.42
4.45
mmol/l
0.06
20
203
18
150
1.60
0.51
2.8
3.8
131.06
47.27
u/l
0.97
18
145
5
31
1.75
0.46
1.4
2.2
—
—
—
0
0
5
34
1.57
0.43
1.4
1.6
1246.20
1347.76
nmol/l
—
5
29
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
0
16
0.00
0.42
0.0
1.1
—
4.91
—
0
11
5
35
1.52
0.42
1.8
2.5
—
—
—
0
0
19
163
1.56
0.39
3.9
4.2
14.72
14.82
pmol/l
0.07
19
149
19
206
0.74
0.31
3.9
3.6
1.37
1.34
mmol/l
0.10
19
187
0
10
0.00
0.22
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
21
194
1.37
0.18
4.3
4.6
2.23
1.92
mu/l
0.45
21
176
21
218
0.84
0.10
42.3
18.0
37.48
40.42
%
1.22
16
176
6
56
1.09
0.09
1.0
2.5
—
—
—
0
0
5
59
0.81
0.09
1.0
2.0
1.63
1.23
mmol/l
—
5
52
20
191
1.18
0.08
30.7
12.3
98.25
86.33
ml/min/173m2
1.80
15
146
18
173
1.12
0.08
3.6
3.6
—
—
—
0
0
10
95
1.08
0.00
3.6
4.8
1.64
1.83
ug/l
—
10
76
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BURKITT – Burkitt lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).